0001553878-18-000027.txt : 20180316
0001553878-18-000027.hdr.sgml : 20180316
20180316170555
ACCESSION NUMBER: 0001553878-18-000027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180314
FILED AS OF DATE: 20180316
DATE AS OF CHANGE: 20180316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vaishnaw Akshay
CENTRAL INDEX KEY: 0001458494
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36407
FILM NUMBER: 18696518
MAIL ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001178670
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770602661
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 551-8200
MAIL ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020724
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2018-03-14
0
0001178670
ALNYLAM PHARMACEUTICALS, INC.
ALNY
0001458494
Vaishnaw Akshay
300 THIRD STREET
CAMBRIDGE
MA
02142
0
1
0
0
President, R&D
Common Stock
2018-03-14
4
M
0
44641
18.66
A
55856
D
Common Stock
2018-03-14
4
M
0
38913
16.43
A
94769
D
Common Stock
2018-03-14
4
M
0
5000
7.1
A
99769
D
Common Stock
2018-03-14
4
S
0
6453
140.45
D
93316
D
Common Stock
2018-03-14
4
S
0
15000
141.69
D
78316
D
Common Stock
2018-03-14
4
S
0
21336
142.57
D
56980
D
Common Stock
2018-03-14
4
S
0
19213
143.46
D
37767
D
Common Stock
2018-03-14
4
S
0
20172
144.53
D
17595
D
Common Stock
2018-03-14
4
S
0
6380
145.27
D
11215
D
Common Stock
338
I
by Managed Account
Stock Option (right to buy)
7.1
2018-03-14
4
M
0
5000
0.0
D
2021-11-30
Common Stock
5000
0
D
Stock Option (right to buy)
16.43
2018-03-14
4
M
0
38913
0.0
D
2019-12-09
Common Stock
38913
0
D
Stock Option (right to buy)
18.66
2018-03-14
4
M
0
44641
0.0
D
2022-12-20
Common Stock
44641
0
D
All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 10, 2018.
Sale prices ranged from $140.00 to $140.95
Sale prices ranged from $141.01 to $142.00
Sale prices ranged from $142.01 to $143.00
Sale prices ranged from $143.01 to $143.98
Sale prices ranged from $144.01 to $145.00
Sale prices ranged from $145.01 to $145.80
The reporting person owns 338 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
By: /s/ Michael P. Mason, Attorney-in-Fact For: Akshay K. Vaishnaw
2018-03-16